Founder and CEO of Tevogen, Dr. Ryan Saadi, donated 10,000 personal shares of common stock to Opportunity Project, a nonprofit in Millburn, N.J. Opportunity Project supports individuals with brain injuries through programs promoting independence and community reintegration. The donation was made in accordance with SEC Rule 144, with Dr. Saadi not receiving any proceeds. Tevogen also released forward-looking statements about its research and growth plans, emphasizing the need for additional capital, the impact of market changes, and potential risks in commercialization and development. Tevogen encourages cautious interpretation of these statements and commits to updating as necessary. Contact Tevogen Bio Communications for more information.

Read more at GlobeNewswire: Tevogen CEO Donates Personal Shares to Support Brain Injury